413 related articles for article (PubMed ID: 14526186)
1. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Inukai A; Sobue G
Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
[TBL] [Abstract][Full Text] [Related]
2. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
Katsuno M; Adachi H; Tanaka F; Sobue G
J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
4. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
Adachi H; Katsuno M; Minamiyama M; Sang C; Pagoulatos G; Angelidis C; Kusakabe M; Yoshiki A; Kobayashi Y; Doyu M; Sobue G
J Neurosci; 2003 Mar; 23(6):2203-11. PubMed ID: 12657679
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of spinal and bulbar muscular atrophy.
McManamny P; Chy HS; Finkelstein DI; Craythorn RG; Crack PJ; Kola I; Cheema SS; Horne MK; Wreford NG; O'Bryan MK; De Kretser DM; Morrison JR
Hum Mol Genet; 2002 Sep; 11(18):2103-11. PubMed ID: 12189162
[TBL] [Abstract][Full Text] [Related]
7. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
[TBL] [Abstract][Full Text] [Related]
8. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G
Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
[TBL] [Abstract][Full Text] [Related]
11. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.
Katsuno M; Adachi H; Kume A; Li M; Nakagomi Y; Niwa H; Sang C; Kobayashi Y; Doyu M; Sobue G
Neuron; 2002 Aug; 35(5):843-54. PubMed ID: 12372280
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Adv Exp Med Biol; 2010; 685():64-74. PubMed ID: 20687495
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
[TBL] [Abstract][Full Text] [Related]
15. [Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):909-11. PubMed ID: 15152501
[TBL] [Abstract][Full Text] [Related]
16. [Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy].
Sobue G
Rinsho Shinkeigaku; 2007 Nov; 47(11):941-3. PubMed ID: 18210842
[TBL] [Abstract][Full Text] [Related]
17. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.
Adachi H; Katsuno M; Minamiyama M; Waza M; Sang C; Nakagomi Y; Kobayashi Y; Tanaka F; Doyu M; Inukai A; Yoshida M; Hashizume Y; Sobue G
Brain; 2005 Mar; 128(Pt 3):659-70. PubMed ID: 15659427
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
19. Spinal and bulbar muscular atrophy.
Lieberman AP
Handb Clin Neurol; 2018; 148():625-632. PubMed ID: 29478604
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
Pennuto M; Basso M
J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]